Assessing the Protective Efficacy of Antibodies to the HIV Gp41 Region by Active Vaccination
Retrovirology - United Kingdom
doi 10.1186/1742-4690-9-s2-p37
Full Text
Open PDFAbstract
Available in full text
Date
September 1, 2012
Authors
Publisher
Springer Science and Business Media LLC